Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum psychosis prevention study
NL-OMON47010Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2013
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of lithium, quetiapine, olanzapine, haloperidol, valproic acid and 2 more in postpartum psychosis (PPP) and bipolar disorder (BD) (3 arms), sponsored by Erasmus MC. Primary endpoint: Peripartum relapse. Started Dec 2013; status: active, not recruiting.
02
Drugs
lithiumquetiapineolanzapinehaloperidolvalproic acid
03
Conditions
postpartum psychosis (PPP)bipolar disorder (BD)
Beyond the preview
Go deeper on NL-OMON47010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47010.